BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31345234)

  • 1. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
    Castro A; Ozturk K; Pyke RM; Xian S; Zanetti M; Carter H
    BMC Med Genomics; 2019 Jul; 12(Suppl 6):107. PubMed ID: 31345234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
    Kawazu M; Ueno T; Saeki K; Sax N; Togashi Y; Kanaseki T; Chida K; Kishigami F; Sato K; Kojima S; Otsuka M; Kawazoe A; Nishinakamura H; Yuka M; Yamamoto Y; Yamashita K; Inoue S; Tanegashima T; Matsubara D; Tane K; Tanaka Y; Iinuma H; Hashiguchi Y; Hazama S; Khor SS; Tokunaga K; Tsuboi M; Niki T; Eto M; Shitara K; Torigoe T; Ishihara S; Aburatani H; Haeno H; Nishikawa H; Mano H
    Gastroenterology; 2022 Mar; 162(3):799-812. PubMed ID: 34687740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies
    Pereira C; Gimenez-Xavier P; Pros E; Pajares MJ; Moro M; Gomez A; Navarro A; Condom E; Moran S; Gomez-Lopez G; Graña O; Rubio-Camarillo M; Martinez-Martí A; Yokota J; Carretero J; Galbis JM; Nadal E; Pisano D; Sozzi G; Felip E; Montuenga LM; Roz L; Villanueva A; Sanchez-Cespedes M
    Clin Cancer Res; 2017 Jun; 23(12):3203-3213. PubMed ID: 28302866
    [No Abstract]   [Full Text] [Related]  

  • 5. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
    Reis B; Attig J; Dziadek S; Graefe N; Heller A; Rieder N; Gomes B
    Front Immunol; 2024; 15():1285049. PubMed ID: 38455061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.
    Tin A; Astor BC; Boerwinkle E; Hoogeveen RC; Coresh J; Kao WH
    Hum Genet; 2013 Jun; 132(6):619-27. PubMed ID: 23417110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High numbers of PDCD1 (PD-1)-positive T cells and
    Janikovits J; Müller M; Krzykalla J; Körner S; Echterdiek F; Lahrmann B; Grabe N; Schneider M; Benner A; Doeberitz MVK; Kloor M
    Oncoimmunology; 2018; 7(2):e1390640. PubMed ID: 29308317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
    Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
    J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-E expression in human tumors.
    Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
    Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors.
    Mumphrey MB; Hosseini N; Parolia A; Geng J; Zou W; Raghavan M; Chinnaiyan A; Cieslik M
    Cell Rep; 2023 Aug; 42(8):112965. PubMed ID: 37597185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.
    Hochman JH; Shimizu Y; DeMars R; Edidin M
    J Immunol; 1988 Apr; 140(7):2322-9. PubMed ID: 2450918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
    Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
    Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CD8
    Shinkawa T; Tokita S; Nakatsugawa M; Kikuchi Y; Kanaseki T; Torigoe T
    Oncoimmunology; 2021 Jan; 10(1):1870062. PubMed ID: 33537174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
    Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
    Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
    Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of HLA.
    Schwartz DW; Felser B; Mayr WR
    Folia Biol (Praha); 1995; 41(3-4):123-39. PubMed ID: 7589710
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses.
    Rao X; Costa AI; van Baarle D; Kesmir C
    J Immunol; 2009 Feb; 182(3):1526-32. PubMed ID: 19155500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.